HR Execs on the Move

B-Line Medical

www.blinemedical.com

 
B-Line Medical is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
LaDonna Ogden
Director, Human Resources and Operations Profile

Similar Companies

Sacred Heart Health System

Sacred Heart Health System, Inc., doing business as Sacred Heart Hospital, provides health care services to children and adults in Northwest Florida. It operates children's and women's hospitals; heart and vascular, and neurology and neurosurgery institutes; emergency/trauma, stroke, cancer, women's services, joint replacement surgery, and weight loss surgery centers; and a network of physicians. The company was founded in 1915 and is based in Pensacola, Florida with hospitals in South Walton County and Gulf County. Sacred Heart Health System, Inc. operates as a subsidiary of Ascension Health.

Cleveland Medical Devices

Cleveland Medical Devices is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Infusion Associates

Infusion Associates is a physician practice that specializes in IV infusions and injections. They provide medically prescribed infusions for patients with chronic disease in a comfortable, outpatient environment instead of a hospital.

Senior Services of Seattle/King County

Senior Services of Seattle/King County is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Senior Services of Seattle/King County is based in Seattle, WA. You can find more information on Senior Services of Seattle/King County at www.seniorservices.org

Cardionomic

Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.